Advisor Group Holdings, Inc. Age X Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.33 - $0.74 $49 - $111	-150 Reduced 4.43%	3,237 $1,000
Q3 2023 Nov 13, 2023	BUY	$0.67 - $0.85 $100 - $127	150 Added 4.63%	3,387 $2,000
Q2 2023 Aug 10, 2023	SELL	$0.45 - $0.89 $22 - $44	-50 Reduced 1.52%	3,237 $2,000
Q1 2022 May 04, 2022	SELL	$0.65 - $1.2 $13 - $24	-20 Reduced 0.6%	3,287 $6,000
Q4 2020 Feb 10, 2021	SELL	$0.8 - $2.56 $84 - $268	-105 Reduced 3.08%	3,307 $5,000
Q3 2020 Nov 12, 2020	BUY	$0.79 - $1.52 $79 - $152	100 Added 3.02%	3,412 $2,000
Q1 2020 May 18, 2020	BUY	$0.78 - $1.95 $2,583 - $6,458	3,312 New	3,312 $3,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.